SCHEMBL9538951

SCHEMBL9538951

C#CC1(C2CC2)c2cc(Cl)ccc2N(Cc2ccc(OC)cc2)C(=O)N1C

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 6/20 0.47
SCN9A Q15858 2/20 0.42
CMA1 P23946 1/20 0.41
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
GSK3A P49840 1/20 0.38
GSK3B P49841 1/20 0.38
CHRM5 P08912 1/20 0.38
OPRL1 P41146 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9542680 0.88 PTGDR2 (0.44) PTGDR2SCN9ACMA1MEN1KMT2A
SCHEMBL9571207 0.88 PTGDR2 (0.45) PTGDR2SCN9ACMA1MEN1KMT2A
SCHEMBL9539980 0.88 PTGDR2 (0.43) PTGDR2SCN9ACMA1MEN1KMT2A
SCHEMBL9571240 0.87 PTGDR2 (0.45) PTGDR2SCN9ACMA1MEN1KMT2A
SCHEMBL9571175 0.87 PTGDR2 (0.47) PTGDR2SCN9ACMA1MEN1KMT2A
SCHEMBL9539989 0.87 PTGDR2 (0.43) PTGDR2SCN9ACMA1MEN1KMT2A
SCHEMBL9571191 0.85 PTGDR2 (0.47) PTGDR2SCN9ACMA1MEN1KMT2A
SCHEMBL9539089 0.85 PTGDR2 (0.51) PTGDR2SCN9ACMA1MEN1KMT2A
SCHEMBL9540099 0.82 PTGDR2 (0.49) PTGDR2SCN9ACMA1MEN1KMT2A
SCHEMBL9540022 0.81 PTGDR2 (0.48) PTGDR2SCN9ACMA1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed